Medtronic plc (0Y6X.L)

81,19 +0,43 (+0,53%) In data: 07:15PM BST. Mercato aperto.

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 95.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Geoffrey Straub Martha	Chairman of the Board & CEO	1,79M	N/D	1970
Ms. Karen L. Parkhill	Executive VP & CFO	992,24k	N/D	1965
Mr. Sean M. Salmon	Executive VP & President of Cardiovascular Portfolio	900,97k	418,71k	1965
Mr. Robert J. W. ten Hoedt	Executive VP & President of Global Regions	1,24M	96,01k	1960
Mr. Mark Ploof	Senior Vice President of Global Operations and Business Services	N/D	N/D	N/D
Ms. Jennifer M. Kirk	Senior VP, Global Controller & Chief Accounting Officer	N/D	N/D	1975
Dr. Kenneth E. Washington Ph.D.	Senior VP and Chief Technology & Innovation Officer	N/D	N/D	1960
Dr. Laura Mauri M.D., M.Sc.	Senior VP and Chief Scientific, Medical & Regulatory Officer	N/D	N/D	N/D
Mr. Ryan Weispfenning	VP & Head of Investor Relations	N/D	N/D	N/D
Mr. Ivan K. Fong	Executive VP, General Counsel & Secretary	985,57k	N/D	1961

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Governance aziendale

L'ISS Governance QualityScore di Medtronic plc al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 5; diritti degli azionisti: 6; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.